Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Prime Medicine (PRME) Other Gross PP&E Adjustments (2021 - 2025)

Prime Medicine filings provide 5 years of Other Gross PP&E Adjustments readings, the most recent being -$96.5 million for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments fell 536.45% to -$96.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$96.5 million, a 536.45% decrease, with the full-year FY2025 number at -$96.5 million, down 536.45% from a year prior.
  • Other Gross PP&E Adjustments hit -$96.5 million in Q4 2025 for Prime Medicine, down from -$77.3 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $22.8 million in Q2 2024 to a low of -$96.5 million in Q4 2025.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$7.8 million (2022), compared with a mean of -$18.7 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: skyrocketed 2515.33% in 2024 and later crashed 536.45% in 2025.
  • Prime Medicine's Other Gross PP&E Adjustments stood at -$5.2 million in 2021, then plummeted by 50.43% to -$7.8 million in 2022, then soared by 288.18% to $14.7 million in 2023, then plummeted by 202.93% to -$15.2 million in 2024, then crashed by 536.45% to -$96.5 million in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were -$96.5 million (Q4 2025), -$77.3 million (Q3 2025), and -$79.7 million (Q2 2025) per Business Quant data.